Biochemical study of HEp2 cells chronically infected with tick-borne encephalitis virus.
D002277:Carcinoma; D002460:Cell Line; D002478:Cells, Cultured / Q000737:chemistry; D003470:Culture Media / Q000032:analysis; D003609:Dactinomycin / Q000494:pharmacology; D004669:Encephalitis Viruses, Tick-Borne / Q000187:drug effects; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology; D007822:Laryngeal Neoplasms; D012367:RNA, Viral / Q000032:analysis*; D012293:Rifampin / Q000494:pharmacology; D014764:Viral Proteins / Q000032:analysis*; D014776:Virus Cultivation
D003470:Culture Media; D007106:Immune Sera; D012367:RNA, Viral; D014764:Viral Proteins; D003609:Dactinomycin; D012293:Rifampin